Diabetes

Top Story

STAMPEDE: Sustained glycemic benefit observed 5 years after gastric bypass in type 2 diabetes, obesity

STAMPEDE: Sustained glycemic benefit observed 5 years after gastric bypass in type 2 diabetes, obesity
February 21, 2017

Patients with type 2 diabetes and mild to moderate obesity who underwent Roux-en-Y gastric bypass or sleeve gastrectomy saw sustained improvements in HbA1c, body weight, lipid levels and quality of life 5 years after surgery that were superior to medical therapy alone, according to results from the STAMPEDE trial.

“Five years is a long time for follow-up, and that is one of the distinguishing features of this study,” Sangeeta Kashyap, MD, of the department of endocrinology, diabetes and metabolism at Cleveland Clinic, told Endocrine Today. “What is remarkable is patients who underwent bariatric surgery had far better glycemic control, with less use of insulin and medications. Almost 90% of patients did not need insulin after surgery. These patients had better triglycerides, higher HDL cholesterol levels, lower C-reactive protein levels, and maintained almost 20% total body weight loss. And, overall, based on their self-reported questionnaires, they had better quality of life.”

In the Journals

Benefits of statin therapy outweigh diabetes risk

February 20, 2017
In a commentary published in The American Journal of Medicine, experts wrote that the CV benefits of statins outweigh any diabetes-related risk they may present
In the Journals

DAPT, aspirin monotherapy confer similar outcomes in patients with diabetes after CABG

February 17, 2017
New data suggest that use of dual antiplatelet therapy may not be clinically warranted in patients with diabetes post-CABG. According to data published in the Journal
In the Journals

Low socioeconomic status as significant a risk factor for mortality as diabetes, high blood pressure, obesity

February 17, 2017
To reduce the risk of mortality, local and global health policies should include efforts to address low socioeconomic status as a contributor to poor health, according
CommentaryPerspective

2016: An active, exciting year in cardiology

Cardiology Today, January 2017
Carl J. Pepine, MD, MACC
The past year has been a very active and exciting one in CVD and CV medicine. We have had major successes on several fronts. Not only was this true…

Cover Story

New knowledge, technologies yield drastic changes in cardiology over 20 years

Cardiology Today, January 2017
Since Cardiology Today was launched 20 years ago in 1997, not only has the prognosis for patients with heart disease vastly changed, but so has the…

In the Journals Plus

Sitagliptin safe, effective for older adults with type 2 diabetes, CVD

January 9, 2017
The DPP-IV inhibitor sitagliptin was safe and effective over 3 years for adults aged at least 75 years who had well-controlled type 2 diabetes and…

In the Journals Plus

Weight loss at 1 year predicts sustained benefit, lower HbA1c in diabetes, obesity

January 6, 2017
Patients with diabetes and obesity who lose at least 7% of their body weight at 1 year are more likely to sustain that weight loss at 5 years along…

In the Journals

Metformin may reduce mortality in patients with certain chronic diseases

January 6, 2017
Recent changes in metformin labeling by the FDA is supported by new findings published in Annals of Internal Medicine that suggest that patients…

Cardiology Today's Top 10 articles posted in 2016

January 6, 2017
Cardiology Today compiled a list of the top 10 stories posted to Healio.com/Cardiology in 2016. This year, Cardiology Today’s readers…

In the Journals

BVS shows efficacy, safety in patients with diabetes

January 5, 2017
An everolimus-eluting bioresorbable vascular scaffold appears to be safe and effective in patients with diabetes, particularly those with baseline…

In the Journals

Younger patients with severe dyslipidemia less likely to receive statins

January 5, 2017
The statin prescription rate for patients with severe dyslipidemia is 66%, with age being the most important predictor, as younger patients are less…

FDA News

CV data added to labels for treatments containing empagliflozin

January 5, 2017
The FDA recently approved supplemental New Drug Applications for type 2 diabetes treatments that include empagliflozin to add in results from the…

Cardiology Today’s top 5 articles posted in December

January 3, 2017
 Cardiology Today compiled a list of the top 5 stories posted to Healio.com/Cardiology in December.

More Headlines »
Advertisement
Advertisement